Simplex Trading
NVCT icon

Simplex Trading’s Nuvectis Pharma NVCT Stock Holding History

Simplex Trading’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1K Buy
+2,596
New +$22.2K ﹤0.01% 6785
2025
Q3 		– Sell
-2,114
Closed -$14.5K – 9740
2025
Q2 		$15K Buy
+2,114
New +$19.2K ﹤0.01% 7018

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's NVCT Position: Q1 2026 in Review

Simplex Trading opened a new position in Nuvectis Pharma (NVCT) in Q1 2026: 2,596 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #6785 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NVCT as recently as Q2 2025.

Simplex Trading first reported a position in NVCT in Q2 2025 and has held it in 2 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Simplex Trading held 2,596 shares of Nuvectis Pharma worth $20.1K as of Q1 2026.
  • Nuvectis Pharma was a new Simplex Trading position in Q1 2026.
  • Nuvectis Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6785 holding.
  • Simplex Trading first reported a position in Nuvectis Pharma in Q2 2025 and has held it in 2 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.